Palo Alto Jumps on Beat, Upgrades; Everpure Climbs on Revenue Beat | MarketReader Minute
U.S. stocks rise on tech rebound amid mixed global markets, while jobless claims and manufacturing index signal labor market strain and weakening demand.
Welcome to the MarketReader Minute.
Below are AI-generated insights on today's premarket moves, powered by MarketReader technology.

Thursday, November 19
Noteworthy macro moves today: Nasdaq 100 Index (US) +1.8%. S&P 500 Index (US) +1.0%. Hang Seng 50 Index (China) -1.9%. Noteworthy US mega-cap moves today: SK Hynix Inc (SKHY) +4.7%. Micron Technology, Inc. (MU) +4.4%. Alphabet Inc. (GOOG) +3.8%.
Global equity indices are trading mixed, with U.S. stocks higher while European and Asian markets show declines. The Nasdaq 100 Index is up significantly, reflecting a rebound in tech stocks following the record-breaking IPO of Anthropic, which raised $81.3 billion, surpassing previous records and boosting investor sentiment in the sector.
In the U.S., initial jobless claims released today rose to 203k for the week ending November 14, slightly above market expectations of 197k. This increase in claims suggests some strain in the labor market; however, continuing claims also rose to 1.763m, indicating ongoing unemployment remains below historical averages.
The Philadelphia Fed Manufacturing Index also released today fell sharply to 6.3 from a previous reading of 20.9, well below forecasts of 20. This decline signals weakening demand within the manufacturing sector as new orders nearly stagnated, although employment indicators showed some resilience amidst rising inflationary pressures.
In Europe, the CBI Industrial Trends Orders report from the UK showed an unexpected improvement with an actual reading of -12 compared to forecasts of -29, suggesting a rebound in industrial orders despite broader economic challenges. Meanwhile, Canada's Raw Materials Prices dropped by 1% month-over-month against expectations for a rise, reflecting declining prices for key commodities.

iShares MSCI South Korea ETF (EWY) [+3.2%]
The iShares MSCI South Korea ETF is advancing in pre-market trading, buoyed by strong gains in key holdings such as SKHY, PKX, and SKM. This upward movement follows a sharp rebound in the KOSPI index after four days of losses, driven by bargain hunting in technology and finance sectors. The positive sentiment is further supported by the U.S. Federal Reserve's October policy meeting minutes, which indicated a consensus for potential rate hikes to address inflation. The Nasdaq 100 Index is also higher since the previous close. Earlier in the session, EWY pulled back from a session high but remains on an upward trajectory as the market prepares to open.
VanEck Semiconductor ETF (SMH) [+3.0%]
NVIDIA's significant revenue increase and positive forecasts have bolstered the semiconductor sector, driving strong performances from key holdings including Micron Technology, Texas Instruments, Broadcom, and Applied Materials. The VanEck Semiconductor ETF is advancing during pre-market trading. Additionally, Micron's outlook for tighter memory supply and Texas Instruments' technological advancements have contributed to the upward momentum. Users on X noted SMH's substantial rise, outperforming other indices like the S&P 500 and Nasdaq-100. One user mentioned a potential preference for software stocks over semiconductors if the market stabilizes soon, while another emphasized SMH as a crucial investment for those optimistic about AI infrastructure expansion.
Vanguard Information Technology ETF (VGT) [+2.3%]
NVIDIA reported a significant increase in revenue and free cash flow, while Microsoft received positive analyst ratings highlighting growth in its Azure business. Additionally, Palo Alto Networks raised its annual revenue forecast and plans to acquire AI startup Applied Compute for $4.5 billion, driving its shares higher. The Vanguard Information Technology ETF is advancing during pre-market hours, supported by these strong gains in key holdings. The Nasdaq 100 Index is also trading higher, reflecting broader market movements influenced by the Federal Reserve's indication of potential interest rate hikes and recent economic data showing a decline in net long-term TIC flows. The Vanguard Information Technology ETF is higher since Wednesday's close.

PANW | +8.6% | +26.2B
Palo Alto Networks, Inc. | Information Technology
Palo Alto Networks, Inc. shares are sharply higher in pre-market trading following multiple bullish price target upgrades from analysts. Mizuho raised its target to $440, while BTIG set a new target of $442. KeyBanc and Citi also adjusted their targets upward to $450 and $445, respectively. This positive sentiment comes after the company reported fiscal first-quarter results that revealed a 39% year-over-year revenue growth to $3.45 billion and an adjusted earnings per share of $1.05, surpassing estimates. CEO Nikesh Arora noted increasing cybersecurity budgets driven by AI threats and highlighted the potential impact of the company's planned $4.5 billion acquisition of Applied Compute on enhancing its AI capabilities. Users on X have expressed optimism about Palo Alto's growth trajectory following these developments.
BE | +6.9% | +3.7B
Bloom Energy Corporation | Industrials
Bloom Energy Corporation was upgraded to Outperform from Market Perform by BMO Capital Markets on November 19, 2026. Analyst Ameet Thakkar adjusted the price target down to $230 from $260 but noted an improved risk-reward profile due to recent execution and a lower share price. The upgrade coincided with the IPO of Anthropic, which is anticipated to spark renewed interest in AI infrastructure, a key growth area for Bloom. BMO highlighted the company's strengthening commercial structure and backlog conversion analysis, forecasting significant revenue growth in 2027. Shares of Bloom Energy are sharply higher during pre-market trading.
P | +7.0% | +2.5B
Everpure Inc | Information Technology
Everpure Inc reported a robust third-quarter performance, with revenue rising 51% year-over-year to $1.46 billion, surpassing Wall Street's estimate of $1.33 billion. The company raised its fiscal 2027 revenue guidance to a range of $5.2 billion to $5.21 billion, up from the previous forecast of $5.03 billion to $5.07 billion, driven by strong demand from hyperscaler customers. Adjusted earnings per share were $0.86, exceeding the consensus estimate of $0.78. Despite the positive results, Barclays lowered its price target for Everpure to $115 from $132 due to concerns over recent product price reductions. In pre-market trading, shares of Everpure are sharply higher. Social media posts noted the company's earnings beat and indicated a positive market response, highlighting a significant uptick in after-hours trading.
ASTS | +8.4% | +0.9B
AST SpaceMobile, Inc. | Communication Services
B. Riley upgraded AST SpaceMobile, Inc. from Neutral to Buy with a price target of $48, citing improved confidence in the company's future amid its partnership with Firefly Aerospace for rocket development. Analyst Mike Crawford noted that previous concerns regarding capital commitments and constellation deployment are now reflected in the stock's pricing. In pre-market trading, shares of AST SpaceMobile are advancing sharply since Wednesday's close. Social media posts highlighted Crawford's upgrade and discussed the valuation drop of the stock, which has fallen from about 545 in early 2026 to approximately 58.7 today. One user expressed skepticism about the management's ability to fulfill its ambitious plans.
HCM | +6.7% | +0.9B
HUTCHMED (China) Ltd | Health Care
HUTCHMED (China) Ltd reported significant preclinical findings for its investigational cancer therapy HMPL-A830, demonstrating effective tumor-cell growth inhibition across multiple KRAS alterations in mouse models, presented at the EORTC-NCI-AACR conference on November 19, 2026. The company also received simultaneous approval from the China National Medical Products Administration for two new drug applications for its oral small molecule inhibitor, SYVIK, which targets immune thrombocytopenia and warm antibody autoimmune hemolytic anemia. This approval, backed by robust clinical trial data, marks a substantial expansion into immunology. Shares are trading sharply higher in pre-market hours following this news.
Thank you for spending a minute with us.
If you have 2 more minutes, watch this demo of the MarketReader Platform:

